Impetigo Treatment is typically treated with an antibiotic ointment or cream that apply directly to the sores.
This report contains market size and forecasts of Impetigo Treatment in Global, including the following market information:
Global Impetigo Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Impetigo Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cephalosporins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Impetigo Treatment include GlaxoSmithKline plc, Karalex Pharma, LLC, Leo Pharma A/S, Lupin Limited, NovaBay Pharmaceuticals, Inc., Pfizer, Inc., Ranbaxy Laboratories Limited, Roche Holding AG and SANDOZ GmbH, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Impetigo Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Impetigo Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Impetigo Treatment Market Segment Percentages, by Type, 2021 (%)
Cephalosporins
Fusidane
Lincosamide Antibiotic
Penicillin
Penicillin-Like Antibiotics
Pleuromutilin
Pseudomonic Acid A
Quinolone
Sulfonamides And Folic Acid Inhibitors
Tetracyclines
Global Impetigo Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Impetigo Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Impetigo Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Impetigo Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Impetigo Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Impetigo Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline plc
Karalex Pharma, LLC
Leo Pharma A/S
Lupin Limited
NovaBay Pharmaceuticals, Inc.
Pfizer, Inc.
Ranbaxy Laboratories Limited
Roche Holding AG
SANDOZ GmbH
Taro Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd